Lexpos News

Community Pharmacy England has seen a large number of products with increases to their list prices on 1 January 2026. Following the price change mechanism rules, price changes for generic products up to and including the 8th of the month take effect for prescriptions dispensed in that same month. Any price changes after the 8th [...]

The post January 2026 reimbursement prices for Omeprazole Rosemont Pharmaceutical Ltd products appeared first on Community Pharmacy England.

Yesterday, Community Pharmacy England joined with the British Dental Association, British Medical Association, Optometric Fees Negotiating Committee and the Association for Primary Care Audiology Providers, to host the “From Crisis to Recovery” The Future of Primary Care parliamentary event. MPs had the opportunity to learn more about primary care services and the professionals who provide [...]

The post From Crisis to Recovery: CPE joins forces with primary care bodies to fight for a secure financial future appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 February 2026. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – February 2026 appeared first on Community Pharmacy England.

In response to the government announcement that all pubs and live music venues will benefit from a 15% business rates relief, with bills also being frozen in real terms for a further two years, we have released the following statement to the press: Our CEO Janet Morrison said: “Unlike GP practices and dental surgeries, the [...]

The post Pharmacies deserve better – end the unfair disparity in business rates relief appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Arixtra solution for injection pre-filled syringes (Viatris Products Ltd) Drug alert number: EL(26)A/04 Date issued: 28 January 2026 Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle. DMRC reference number:DMRC-38220370 Marketing [...]

The post MHRA Class 4 Medicines Defect Notification: Arixtra solution for injection pre-filled syringes (Viatris Products Ltd) appeared first on Community Pharmacy England.